alexion pharmaceuticals inc
(ALXN:Consolidated Issue Listed on NASDAQ Global Select )
Martin MacKay Ph.D.
Global Head of Research & Development and Executive Vice President , Alexion Pharmaceuticals, Inc.
|Age||Total Calculated Compensation||This person is connected to 0 board members in 0 different organizations across 5 different industries.|
As of Fiscal Year 2014
Dr. Martin Mackay has been Global Head of Research & Development and Executive Vice President at Alexion Pharmaceuticals, Inc. since May 2013. Dr. Mackay served as the President of R&D at AstraZeneca PLC from July 1, 2010 to January 31, 2013. Dr. Mackay led AstraZeneca's research and development organisation and had overall accountability for delivering new products - small molecules and biologics - from its pipeline. Dr. Mackay served as President of PharmaTherapeutics ...
352 Knotter DrivePhone: 203-272-2596
Cheshire, Connecticut 06410
Board Members Memberships*
University of Edinburgh in Scotland
|Robert W. Duggan||Chairman and Chief Executive Officer|
|Rakesh Sachdev||Chief Executive Officer, President and Director|
|Heinz-Jurgen Bertram Ph.D.||Chairman of Executive Board, Chief Executive Officer and Labour Director|
|Gunupati Venkateswara Prasad B.Sc. (Chem. Eng.), M.S. (Indl. Admn.)||Co-Chairman, Chief Executive Officer, Member of The Management Council, Director, Member of Management Committee, Member of Stakeholders' Relationship Committee, Member of Investment Committee and Member of Corporate Social Responsibility Committee|
Dr. Reddy's Laboratories Ltd.
|6.3M||Compensation as of Fiscal Year 2014.|